Manandhar, Nora Ranjitkar, Gyan Krishna Kayashta, and Paras Kumar Acharya. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences 5, no. 1 (June 29, 2018): 47–56. Accessed November 21, 2024. https://nepjol.info./index.php/JPAHS/article/view/24042.